Alkem Laboratories Ltd.
BSE: 539523 | Sector: Health care |
NSE: ALKEM | ISIN Code: INE540L01014 |
BSE 00:00 | 27 Jan | 2997.60 |
-16.20 (-0.54%) |
OPEN
3008.05 |
HIGH
3033.95 |
LOW
2980.10 |
NSE 00:00 | 27 Jan | 3000.70 |
-19.50 (-0.65%) |
OPEN
3022.80 |
HIGH
3040.00 |
LOW
2985.00 |
OPEN | 3008.05 |
PREVIOUS CLOSE | 3013.80 |
VOLUME | 794 |
52-Week high | 3720.00 |
52-Week low | 2835.00 |
P/E | 35.67 |
Mkt Cap.(Rs cr) | 35,836 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Alkem Laboratories Ltd. (ALKEM) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 6823.50 | 5302.21 | 4989.56 | 4246.25 | 4125.82 |
Other Income | 145.66 | 141.24 | 70.06 | 48.51 | 75.93 |
Total Income | 6969.16 | 5443.45 | 5059.62 | 4294.76 | 4201.75 |
Total Expenditure | 5212.83 | 3769.69 | 3875.69 | 3438.55 | 3227.63 |
Operating Profit | 1756.33 | 1673.76 | 1183.93 | 856.21 | 974.12 |
Interest | 24.82 | 35.57 | 29.20 | 26.81 | 26.01 |
Gross Profit | 1731.51 | 1638.19 | 1154.73 | 829.40 | 948.11 |
Depreciation | 163.97 | 149.55 | 123.08 | 100.09 | 77.47 |
PBT | 1567.54 | 1488.64 | 1031.65 | 729.31 | 870.64 |
Tax | 271.41 | 260.89 | 148.83 | 154.64 | 202.87 |
Net Profit/(Loss) | 1464.37 | 1322.34 | 993.21 | 609.02 | 655.85 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 1464.37 | 1322.34 | 993.21 | 609.02 | 655.85 |
Equity Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 122.47 | 110.60 | 83.07 | 50.94 | 54.85 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Alkem Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices